Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised... by Gregorc, Vanesa, Dr, Novello, Silvia, MD, Lazzari, Chiara, MD, Barni, Sandro, MD, Aieta, Michele, MD, Mencoboni, Manlio, MD, Grossi, Francesco, MD, Pas, Tommaso De, MD, de Marinis, Filippo, MD, Bearz, Alessandra, MD, Floriani, Irene, PhD, Torri, Valter, MD, Bulotta, Alessandra, MD, Cattaneo, Angela, Grigorieva, Julia, PhD, Tsypin, Maxim, PhD, Roder, Joanna, PhD, Doglioni, Claudio, Prof, Levra, Matteo Giaj, MD, Petrelli, Fausto, MD, Foti, Silvia, MD, Viganò, Mariagrazia, MD, Bachi, Angela, PhD, Roder, Heinrich, PhD

Get full text